Results 181 to 190 of about 72,925 (303)

Effect of Cervical Epidural STimulation After Neurological Damage: protocol for phase I/II open label controlled CE-STAND trial. [PDF]

BMJ Open
Mansour N, Keller-Ross M, Low W, Balser DY, Parr A.   +4 more
europepmc   +1 more source

A cross‐consortium, stakeholder‐driven model for implementing a modern electronic data capture and submission system across the Alzheimer's Disease Research Centers Program

Alzheimer's &Dementia, Volume 22, Issue 3, March 2026.
Abstract INTRODUCTION The National Alzheimer's Coordinating Center (NACC) and Alzheimer's Disease Research Center (ADRC) Program advances dementia research by collecting and sharing standardized, longitudinal data, including the Uniform Data Set with the global research community. To modernize workflow and accelerate the availability of analyzable data,
Sarah Biber, Sarah Gothard, Charles F Murchison, Laura McLeod, Kathryn Gauthreaux, Chandima HewaNadungodage, Emily Cheng, Jessica Welsch, Jessica E. Culhane, Sarah Yasuda, Hannah Stockwell, Shilpa Allimatti, Mark Bauer, Jonathan M. Reader, Walter Kukull, Meredith Zozus, Sudeshna Das   +16 more
wiley   +1 more source

A real-world data challenge: guidance for aligning data privacy compliance and fit-for-purpose usability. [PDF]

Health Aff Sch
Jaffe DH, Malin BA, Hendricks-Sturrup RM.   +2 more
europepmc   +1 more source

Accelerating real‐world prediction and research in Alzheimer's: The M3AD study

Alzheimer's &Dementia, Volume 22, Issue 3, March 2026.
Abstract Chronic diseases, including Alzheimer's disease (AD) and related dementia (ADRD), do not exist solely as isolated entities. Instead, they weave concomitant trajectories of multiple diseases, conditions, behaviors, and risks, mutually influencing each other's course and natural history, in ways yet unexplored.
Moïse Desvarieux, Tatjana Rundek, Habibul Ahsan, Javier Narvaez, Felipe Diaz, Daniel Malinsky, Luis Marco Ruiz, Maxim Topaz, Thomas Falconer, Karthik Natarajan, James Noble, Barbara Entwisle, Deepthi Puram, Tara Anand, Hsin Yi Chen, Xinzhuo Jiang, Yian Gu, Alan Cohen, Mary Beth Terry, Brandon Pierce, Howard Andrews, Emily Rogalsky, Shahla Farzana, George Gulotta, John Beard, Danielle Landron, Samuel L Volchenboum, Philippe Ravaud, Julie Johnson, Ezra Susser, Andrew Rundle, Ying Wei, Nick Tsinoremas, David Loewenstein, Linda Fried, Allison Aiello, Richard Mayeux, George Hripcsak   +37 more
wiley   +1 more source

AN AUTOMATED MODEL-BASED TEST TRANSACTION GENERATOR FOR HIPAA COMPLIANCE [PDF]

Issues in Information Systems, 2004
Michel Mitri, Abdul Tannir
doaj  

Health-FedNet: secure federated learning for chronic disease prediction on MIMIC-III with differential privacy and homomorphic encryption. [PDF]

Sci Rep
Shahid MI, Badar HMS, Asghar MN, Abdullah A.   +3 more
europepmc   +1 more source

Integrating real‐world data with gold‐standard longitudinal clinical and genomic data to advance precision medicine for the Alzheimer's Disease Research Center Program and beyond: a proof‐of‐concept data platform

Alzheimer's &Dementia, Volume 22, Issue 3, March 2026.
Abstract INTRODUCTION Integrating real‐world data (RWD) with clinical research datasets creates more complete, context‐rich resources to drive discovery and enable precision medicine in Alzheimer's disease and related dementias. The National Alzheimer's Coordinating Center conducted a proof‐of‐concept (POC) project to link its longitudinal Uniform Data
Sarah Biber, Jessica E. Culhane, Maria G. Prado, Satish Mathew, Yohali Burrola‐Mendez, Imara I. West, Sarah Van Heiden, Jimmy Phuong, Shilpa Allimatti, Liam G. Lane, Krista L. Moulder, Brittany K. Hale, Amanda Kuzma, Li‐San Wang, Sujuan Gao, Albert Lai, Karthik Natarajan, Sophia Wang, John C. Morris, James M. Noble, Sean D. Mooney, Walter Kukull, Andrew J. Saykin, Kari A. Stephens   +23 more
wiley   +1 more source

CUSTOMER PRIVACY CAN BE COSTLY: THE CASE OF HIPAA [PDF]

Issues in Information Systems, 2009
Wallace Wood
doaj  

OpenEvidence. [PDF]

J Med Libr Assoc
Philip S, Kurian R.
europepmc   +1 more source

Association of Abatacept With Lower Mortality Risk Compared to Rituximab in Rheumatoid Arthritis–Associated Interstitial Lung Disease: An Emulated Target Trial

Arthritis &Rheumatology, Volume 78, Issue 3, Page 592-602, March 2026.
Objective The optimal treatment strategy for rheumatoid arthritis–associated interstitial lung disease (RA‐ILD) remains uncertain, and direct comparative data between biologics are limited. This study aimed to evaluate the effectiveness and safety of abatacept compared with rituximab in patients with RA‐ILD.
Po‐Cheng Shih, Shiow‐Ing Wang, James Cheng Chung Wei   +2 more
wiley   +1 more source